OPIANT PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Issued from Q2 2011 to Q3 2022

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Opiant Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q2 2011 to Q3 2022.
  • Opiant Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2022 was 5.16M shares, a 11.8% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 5.16M +547K +11.8% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 5.12M +773K +17.8% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 5.08M +749K +17.3% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 4.91M +652K +15.3% Dec 31, 2021 10-Q 2022-11-14
Q3 2021 4.62M +360K +8.46% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 4.35M +91.5K +2.15% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 4.33M +72.5K +1.7% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 4.26M 0 0% Dec 31, 2020 10-K 2022-03-15
Q3 2020 4.26M +183K +4.5% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 4.26M +233K +5.78% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 4.26M +333K +8.48% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 4.26M +413K +10.7% Dec 31, 2019 10-K 2021-03-04
Q3 2019 4.07M +279K +7.36% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 4.03M +1.31M +48.5% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 3.93M +1.34M +51.7% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 3.85M +1.31M +51.6% Dec 31, 2018 10-K 2020-03-04
Q3 2018 3.8M +1.76M +86.2% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 2.71M +685K +33.8% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 2.59M +566K +28% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 2.54M +528K +26.3% Dec 31, 2017 10-K 2019-03-21
Q3 2017 2.04M +45.5K +2.28% Oct 31, 2017 10-Q 2017-12-04
Q2 2017 2.03M +34.2K +1.72% Jul 31, 2017 10-K 2019-03-21
Q1 2017 2.02M +38.9K +1.97% Apr 30, 2017 10-Q 2017-06-14
Q4 2016 2.01M +121K +6.41% Jan 31, 2017 10-Q 2017-03-15
Q3 2016 1.99M +127K +6.8% Oct 31, 2016 10-Q 2016-12-15
Q2 2016 1.99M +151K +8.18% Jul 31, 2016 10-KT 2018-03-07
Q1 2016 1.98M +154K +8.45% Apr 30, 2016 10-Q 2016-06-08
Q4 2015 1.89M +66.9K +3.68% Jan 31, 2016 10-Q 2016-03-15
Q3 2015 1.87M -177M -99% Oct 31, 2015 10-Q 2015-12-14
Q2 2015 1.84M +59.8K +3.36% Jul 31, 2015 10-K 2016-10-28
Q1 2015 1.83M -176M -99% Mar 12, 2015 10-K 2015-10-26
Q4 2014 1.82M -176M -99% Dec 31, 2014 10-K 2016-10-28
Q3 2014 179M +10.6M +6.28% Oct 31, 2014 10-Q 2014-12-09
Q2 2014 1.78M -163M -98.9% Jul 31, 2014 10-K 2015-10-26
Q1 2014 178M +32.4M +22.2% Apr 30, 2014 10-Q 2014-06-10
Q4 2013 178M +45.4M +34.2% Jan 31, 2014 10-Q 2014-03-17
Q3 2013 168M +37.8M +28.9% Oct 31, 2013 10-Q 2013-12-16
Q2 2013 165M +38.6M +30.6% Jul 31, 2013 10-K 2014-10-27
Q1 2013 146M +28.5M +24.3% Apr 30, 2013 10-Q 2013-06-14
Q4 2012 133M +28.4M +27.2% Jan 31, 2013 10-Q 2013-03-18
Q3 2012 131M +38.6M +42% Oct 31, 2012 10-Q 2012-12-20
Q2 2012 126M +49.1M +63.8% Jul 31, 2012 10-K 2013-10-29
Q1 2012 117M Apr 30, 2012 10-Q 2012-06-14
Q4 2011 104M Jan 31, 2012 10-Q 2012-03-16
Q3 2011 92M Oct 31, 2011 10-Q 2011-12-15
Q2 2011 77M Jul 31, 2011 10-K/A 2012-11-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.